Crizanlizumab (SEG101)

crizanlizumab · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Crizanlizumab (SEG101), covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Managed Access Programs for SEG101, Crizanlizumab